Skip to main content
Have a personal or library account? Click to login
Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells Cover

Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells

Open Access
|Aug 2018

Full Article

Abbreviations:

DMEM:

Dulbecco´s Modified Eagle medium;

DOX:

Doxorubicin;

EDTA:

Ethylenediamine tetraacetic acid;

EMA:

European Medicines Agency;

FBS:

Fetal bovine serum;

FDA:

Food and Drug Administration;

HBSS:

Hanks’ balanced salt solution;

MTT:

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide;

MTX:

Mitoxantrone;

NHL:

Non-Hodgkin’s lymphoma;

NR:

Neutral Red;

PBS:

Phosphate buffered saline;

PIX:

Pixantrone;

RA:

Retinoic acid;

ROS:

Reactive oxygen species

DOI: https://doi.org/10.2478/intox-2018-0002 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 13 - 21
Submitted on: Feb 2, 2018
Accepted on: May 14, 2018
Published on: Aug 6, 2018
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2018 Ana Reis-Mendes, Marisa Alves, Félix Carvalho, Fernando Remião, Maria Lourdes Bastos, Vera Marisa Costa, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.